Hemodynamic effects of oxprenolol alone and combined with nitroglycerin in patients with ischemic heart disease.
D000284:Administration, Oral; D000328:Adult; D000787:Angina Pectoris; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D006328:Cardiac Catheterization; D002306:Cardiac Volume / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D003864:Depression, Chemical; D005080:Exercise Test; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010096:Oxprenolol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D005082:Physical Exertion; D014655:Vascular Resistance / Q000187:drug effects
D002245:Carbon Dioxide; D010096:Oxprenolol; D005996:Nitroglycerin; D010100:Oxygen